| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90682-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90423-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90030-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09028-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11977-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81095-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52647-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52697-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2708-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81101-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12065-0.025mg | |||
![Immunohistochemistry: BLIMP1/PRDM1 Antibody [NBP3-10875] - Immunohistochemistry with spleen cell lysate tissue at an antibody concentration of 5.0ug/ml](http://images.novusbio.com/fullsize/BLIMP1-PRDM1-Antibody-Immunohistochemistry-NBP3-10875-img0001.jpg "Immunohistochemistry: BLIMP1/PRDM1 Antibody [NBP3-10875] - Immunohistochemistry with spleen cell lysate tissue at an antibody concentration of 5.0ug/ml")
![Flow Cytometry: CD23/Fc epsilon RII Antibody (007) [NBP2-90682] - Flow cytometric analysis of Mouse CD23/Fc epsilon RII expression on BABL/c splenocytes. Cells were stained with purified anti-Mouse CD23/Fc epsilon RII, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-007-Flow-Cytometry-NBP2-90682-img0001.jpg "Flow Cytometry: CD23/Fc epsilon RII Antibody (007) [NBP2-90682] - Flow cytometric analysis of Mouse CD23/Fc epsilon RII expression on BABL/c splenocytes. Cells were stained with purified anti-Mouse CD23/Fc epsilon RII, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![Immunocytochemistry/Immunofluorescence: CD23/Fc epsilon RII Antibody (007) [NBP2-90682] - Immunofluorescence staining of mouse CD23/Fc epsilon RII in mouse splenocytes. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with NBP2-90682 antibody (1:60) at 4C overnight. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG Secondary antibody (green) and counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/nbp2-90682_rabbit-monoclonal-cd23-fc-epsilon-rii-antibody-007-235202511354120.png)
![Flow Cytometry: CD27/TNFRSF7 Antibody (012) [NBP2-90423] - Expression of CD27/TNFRSF7 on mouse splenocytes. BABL/c splenocytes were stained with purified mAb R012, then a FITC-conjugated second step antibody . Flow cytometry was performed on a BD FACSCalibur(TM) flow cytometry system.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-012-Flow-Cytometry-NBP2-90423-img0001.jpg "Flow Cytometry: CD27/TNFRSF7 Antibody (012) [NBP2-90423] - Expression of CD27/TNFRSF7 on mouse splenocytes. BABL/c splenocytes were stained with purified mAb R012, then a FITC-conjugated second step antibody . Flow cytometry was performed on a BD FACSCalibur(TM) flow cytometry system.")
![Immunocytochemistry/Immunofluorescence: CD27/TNFRSF7 Antibody (012) [NBP2-90423] - Immunofluorescence staining of Mouse CD27/TNFRSF7 in Mouse Spleen cells. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with NBP2-90423 antibody (1:60) at 37C 1 hour. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG secondary antibody (green). Positive staining was localized to cell membrane.](http://images.novusbio.com/fullsize/nbp2-90423_rabbit-monoclonal-cd27-tnfrsf7-antibody-012-23520251664768.png)
![Immunohistochemistry-Paraffin: Siglec-2/CD22 Antibody (340) [NBP2-90030] - Staining of human CD22 in human tonsil with rabbit monoclonal antibody at 1:200 dilution.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-340-Immunohistochemistry-Paraffin-NBP2-90030-img0003.jpg "Immunohistochemistry-Paraffin: Siglec-2/CD22 Antibody (340) [NBP2-90030] - Staining of human CD22 in human tonsil with rabbit monoclonal antibody at 1:200 dilution.")
![Immunohistochemistry-Paraffin: Siglec-2/CD22 Antibody (340) [NBP2-90030] - Staining of human CD22 in human spleen with rabbit monoclonal antibody at 1:200 dilution.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-340-Immunohistochemistry-Paraffin-NBP2-90030-img0002.jpg)
![Flow Cytometry: CD38 Antibody (HB7) - Chimeric [NBP2-52647] - CD38 Antibody (HB7) [NBP2-52647] - Flow Cytometry using anti-CD38 antibody HB7. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of HB7 (NBP2-52647, panel B) at a concentration of 1 ug/mL for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow cytometer.](http://images.novusbio.com/fullsize/CD38-Antibody-HB7-Chimeric-Flow-Cytometry-NBP2-52647-img0001.jpg "Flow Cytometry: CD38 Antibody (HB7) - Chimeric [NBP2-52647] - CD38 Antibody (HB7) [NBP2-52647] - Flow Cytometry using anti-CD38 antibody HB7. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of HB7 (NBP2-52647, panel B) at a concentration of 1 ug/mL for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow cytometer.")
![Immunocytochemistry/Immunofluorescence: CD40/TNFRSF5 Antibody (A54 scFv) [NBP2-81101] - Immunofluorescence staining of fixed Daudi cells with [NBP2-81101]. Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of A54 scFv [NBP2-81101] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81101, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-A54-scFv-Immunocytochemistry-Immunofluorescence-NBP2-81101-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD40/TNFRSF5 Antibody (A54 scFv) [NBP2-81101] - Immunofluorescence staining of fixed Daudi cells with [NBP2-81101]. Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of A54 scFv [NBP2-81101] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81101, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")
![Immunocytochemistry/Immunofluorescence: CD19 Antibody (CAT-13.1E10) - Chimeric [NBP3-12065] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of CAT-13.1E10 (NBP3-12065) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12065, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CD19-Antibody-CAT-13-1E10-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12065-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD19 Antibody (CAT-13.1E10) - Chimeric [NBP3-12065] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of CAT-13.1E10 (NBP3-12065) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12065, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: CD19 Antibody (CAT-13.1E10) - Chimeric - Azide and BSA Free [NBP3-12065] - Paraformaldehyde fixed Daudi cells were stained with anti-unknown specificity antibody (isotype control, black line) or NBP3-12065 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-12065_rabbit-monoclonal-cd19-antibody-cat-13-1e10-chimeric-74202522113010.png)